Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(NY:
MAIA
)
3.430
+0.100 (+3.00%)
Official Closing Price
Updated: 8:00 PM EDT, Jul 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about MAIA
< Previous
1
2
3
Next >
MAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA’s Approval of a Telomerase Inhibitor Agent Therapy
June 07, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology (MAIA): Pioneering New Frontiers in NSCLC Treatment with THIO
June 07, 2024
Via
AB Newswire
MAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer Agent
June 06, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
Groundbreaking Study by MAIA Biotechnology (NYSE: MAIA) Indicates Promising New Treatment for Advanced Lung Cancer
June 06, 2024
Via
AB Newswire
MAIA Biotechnology Reveals New Clinical Data Showing THIO’s Strong Efficacy in Non-Small Cell Lung Cancer
June 04, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology (MAIA) to Showcase Groundbreaking Telomere-Targeting Cancer Treatments at BIO International Convention 2024
June 04, 2024
Via
AB Newswire
MAIA Biotechnology Inc (MAIA) Stock Surges as Company Prepares to Present Promising Data at BIO International Convention
May 31, 2024
Via
AB Newswire
MAIA Biotechnology (NYSE: MAIA) Makes Strategic Moves: Key Presentations, New Funding, and Leadership Changes Drive Innovation
May 21, 2024
Via
AB Newswire
MAIA Biotechnology to Present at the BIO International Convention 2024
May 17, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Abstract Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
May 16, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement
April 30, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private Placement
April 29, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Announces $1.00 Million Private Placement
April 23, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology to Present at Two Investor Conferences in April 2024
April 05, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Announces Share Purchases by Directors Cristian Luput and Ramiro Guerrero
March 28, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement
March 26, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Announces $1.33 Million Private Placement
March 26, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Announces Share Purchase by Director Stan Smith, PhD in a $2.9 Million Private Placement
March 22, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Welcomes Prominent Medical Oncology Scientist Dr. Saadettin Kilickap to its Scientific Advisory Board
March 21, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology to Participate in the 36th Annual ROTH Conference
March 07, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology and Nationwide Children’s Hospital Announce Presentation of THIO’s Potency in Pediatric Brain Tumors at American Association of Cancer Research Annual Meeting
March 06, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Announces Strong Efficacy of THIO as Third-Line Treatment for Non-Small Cell Lung Cancer Patients
March 06, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology CEO Details Immuno-Oncology Cancer Treatment Candidates and Development Pipeline in Letter to Shareholders
March 05, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Announces Publication in Nature Communications on Positive Effects of THIO for Potential Treatment of Small Cell Lung Cancer
February 07, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Announces Publication of International PCT Patent Application Covering Anticancer Telomere-Targeting Compounds
January 24, 2024
From
MAIA Biotechnology
Via
Business Wire
MAIA Biotechnology Provides Positive Phase 2 Clinical Updates for Lead Anticancer Agent and Outlines Targeted Milestones for 2024
January 17, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology to Present at Biotech Showcase 2024 on January 9, 2024
January 05, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Announces Dose Selection in THIO-101 Phase 2 Clinical Trial for Non-Small Cell Lung Cancer
December 19, 2023
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Announces Closing of $4 Million Registered Direct Offering
November 17, 2023
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology (NYSE: MAIA) Has Received FDA Orphan Drug Designation For THIO As A Treatment For Most Aggressive Brain Cancer
November 17, 2023
Via
ACCESSWIRE
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.